financetom
Business
financetom
/
Business
/
Honeywell Bets On Growth With New Segment Strategy And Spin-Off Plans
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Honeywell Bets On Growth With New Segment Strategy And Spin-Off Plans
Oct 23, 2025 6:05 AM

Honeywell International Inc ( HON ). on Thursday reported third-quarter 2025 results that beat Wall Street expectations and raised its full-year earnings and sales outlook.

Details

The company posted adjusted earnings of $2.82 per share, topping analysts’ estimates of $2.57.

Revenue for the quarter rose 7% year over year (Y/Y) to $10.41 billion, beating expectations of $10.14 billion.

Also Read: Dow Dips Over 300 Points Amid Trade Concerns: Investor Fear Increases, Greed Index Remains In ‘Fear’ Zone

Organic sales increased 6% Y/Y, aided by double-digit growth in commercial aftermarket and defense and space.

Operating income declined 6% Y/Y, and segment profit increased 5% to $2.4 billion. This was led by strength in Energy and Sustainability Solutions and Building Automation segments.

The operating margin contracted 220 basis points to 16.9% and segment margin contracted 50 basis points to 23.1%.

Operating cash flow was $3.3 billion, up 65% Y/Y, and free cash flow was $1.5 billion, down 16% Y/Y in the quarter.

Segment Performance

Segment results were mixed. Aerospace Technologies generated $4.51 billion in sales, up 12% Y/Y organically. However, segment margins declined 160 basis points due to cost inflation and recent acquisitions.

Building Automation posted $1.88 billion in sales with 7% Y/Y organic growth and an 80 basis-point margin expansion led by volume leverage and strong commercial operation.

Industrial Automation reported $2.27 billion in sales, up 1% Y/Y on an organic basis. However, segment margins contracted 150 basis points Y/Y due to cost inflation.

Energy and Sustainability Solutions recorded $1.74 billion in sales, down 2% Y/Y organically. UOP sales fell 13% Y/Y due to expected licensing delays and weak catalyst shipment volumes. However, segment margins remained flat Y/Y in the quarter.

Outlook

Honeywell ( HON ) raised its 2025 adjusted EPS guidance to $10.60 – $10.70 from $10.45 – $10.65, versus the consensus of $10.54.

However, the company lowered its full-year sales outlook to $40.7 billion-$40.9 billion, from $40.8 billion-$41.3 billion, versus a consensus of $40.84 billion.

Honeywell ( HON ) now expects operating cash flow to be between $6.4 billion-$6.8 billion (versus $6.7 billion-$7.1 billion prior), and free cash flow of $5.2 billion-$5.6 billion (versus $5.4 billion and $5.8 billion prior).

Excluding the Bombardier settlement, it forecasts 5% organic sales growth, segment margin down 40 to 30 basis points, and adjusted EPS up about 3% for the year.

Management Commentary

Vimal Kapur, chairman and chief executive officer of Honeywell ( HON ), stated, “Increased orders across our business segments pushed the company’s total backlog to another record high and reinforced the benefit of the new, innovative solutions we are delivering for customers. All of this translated to us exceeding the high end of our guidance for both organic growth and adjusted earnings per share in the quarter.”

Portfolio Restructuring

Honeywell ( HON ) disclosed an updated business segment structure in preparation for two upcoming separations.

Effective January 1, 2026, Honeywell ( HON ) will adopt a new structure for its reporting segments: Aerospace Technologies, Building Automation, Industrial Automation, and Process Automation and Technology.

Notably, the company plans to spin off its Solstice Advanced Materials business by October 30, 2025, followed by the planned separation of its Aerospace Technologies business in the second half of 2026.

Investors can gain exposure to the stock via Themes Transatlantic Defense ETF ( NATO ) and EA Series Trust Castellan Targeted Income ETF .

Price Action: HON shares were trading higher by 4.17% to $215.23 premarket at last check Thursday.

Read Next:

Honeywell Partners With LS Electric To Boost Data Center Power Efficiency

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved